5-azacytidine in childhood leukemia.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001853:Bone Marrow / Q000187:drug effects; D002648:Child; D002675:Child, Preschool; D003562:Cytidine / Q000627:therapeutic use; D004361:Drug Tolerance; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D007951:Leukemia, Myeloid / Q000188:drug therapy; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D007958:Leukocyte Count; D007962:Leukocytes / Q000187:drug effects; D015122:Mercaptopurine / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D012075:Remission, Spontaneous; D013843:Thiazines / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D013843:Thiazines; D003562:Cytidine; D014750:Vincristine; D015122:Mercaptopurine; D011241:Prednisone